Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin intervention in pulmonary embolism and chronic thromboembolic pulmonary hypertension
ChiCTR-TNRC-08000263Phase 4Completed
- Sponsor
- Tongji Hospital
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of atorvastatin in pulmonary embolism (PE) and chronic thromboembolic pulmonary hypertension (CTEPH) (2 arms), sponsored by Tongji Hospital. Primary endpoints: Venous blood biochemical index, Cardiac and pulmonary function classification and 2 more. Started Jun 2008; status: completed.
02
Drugs
atorvastatin
03
Conditions
pulmonary embolism (PE)chronic thromboembolic pulmonary hypertension (CTEPH)
Beyond the preview
Go deeper on ChiCTR-TNRC-08000263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-08000263.